🌍Stalecollected in 66m

Thena Capital closes £45M fund for UK medtech

Thena Capital closes £45M fund for UK medtech
PostLinkedIn
🌍Read original on The Next Web (TNW)

💡New £45M capital pool specifically for UK medtech startups—a key funding source for AI-enabled health tools.

⚡ 30-Second TL;DR

What Changed

Fund size reached £45 million ($60.4 million).

Why It Matters

This signals increased capital availability for UK-based AI-driven healthcare and medtech startups. It highlights a growing trend of specialized venture capital supporting niche deep-tech sectors.

What To Do Next

If you are a UK-based medtech founder, monitor Thena Capital's portfolio and investment criteria for potential seed-stage funding opportunities.

Who should care:Founders & Product Leaders

Key Points

  • Fund size reached £45 million ($60.4 million).
  • Focuses exclusively on early-stage UK medtech companies.
  • First all-female GP team to close a fund of this scale in the UK.
  • Follows a £27 million initial close in March 2025.

🧠 Deep Insight

Web-grounded analysis with 8 cited sources.

🔑 Enhanced Key Takeaways

  • The fund is anchored by the British Business Bank's Enterprise Capital Funds (ECF) programme, making Thena Capital the first all-female General Partner-led fund to receive ECF backing in the UK.
  • Thena Capital employs a 'gender-smart' investment strategy, focusing on diverse teams and products designed for both women and men, with approximately 25% of the fund specifically allocated to women's health initiatives.
  • The firm plans to invest in around 25 early-stage companies, providing initial cheques ranging from £500,000 to £1 million, with a strong emphasis on supporting their expansion from the UK into global markets, particularly the United States.
  • Over 50% of Thena Capital's limited partners (LPs) are women, and the investor base includes prominent figures such as Baroness Martha Lane Fox and senior executives from major pharmaceutical companies like GSK, Novartis, and AstraZeneca, offering strategic value beyond capital.
  • Founded in 2021 by healthcare industry veterans Dr. Pamela Walker Geddes, Esther Reynal de St Michel Richardot, and Tatum Getty, the team also established the 'Future of HealthTech Hub' community prior to launching the fund.

🔮 Future ImplicationsAI analysis grounded in cited sources

Increased investment in underserved areas of UK medtech, particularly women's health.
Thena Capital's explicit 'gender-smart' investment strategy and dedicated allocation to women's health, coupled with its mission to address an equity gap in the UK medtech sector, are expected to channel more capital into these historically underfunded segments.
Enhanced diversity within the UK venture capital landscape.
As the first all-female General Partner team to secure backing from the British Business Bank's ECF programme, Thena Capital establishes a significant precedent, potentially inspiring and facilitating the emergence of more diverse fund managers in the UK VC ecosystem.
Accelerated global expansion for UK medtech startups.
Thena Capital's investment thesis specifically focuses on enabling portfolio companies to scale from their UK origins into international markets, especially the US, leveraging the founders' transatlantic experience and a strategically built network of global LPs.

Timeline

2021
Thena Capital founded
2025-03
Initial close of Fund I at £27 million
2025-03-21
Celebrated first close with a Market Open Ceremony at the London Stock Exchange
2025-07-08
Made first investment of £1 million in Plexāā for its breast cancer device
2026-06-12
Final close of inaugural Fund I at £45 million

📎 Sources (8)

Factual claims are grounded in the sources below. Forward-looking analysis is AI-generated interpretation.

  1. everythingstartups.com
  2. thenextweb.com
  3. techfundingnews.com
  4. med-tech.world
  5. superscout.co
  6. londonstockexchange.com
  7. youtube.com
  8. citeline.com
📰

Weekly AI Recap

Read this week's curated digest of top AI events →

👉Related Updates

AI-curated news aggregator. All content rights belong to original publishers.
Original source: The Next Web (TNW)